FindTrial
Sign In

Effectiveness of Etoricoxib 120 mg in Pain Relief during IUD Insertion; A Randomized, Double-blinded, Placebo controlled, Clinical Trial

Effectiveness of Etoricoxib 120 mg in Pain Relief during IUD Insertion ; A Randomized, Double-blinded, Placebo controlled, Clinical Trial ’

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160811002
Enrollment
130
Registered
2016-08-11
Start date
2016-04-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effectiveness of Etoricoxib 120 mg in Pain Relief during IUD Insertion

Interventions

To compare the efficacy of Etoricoxib 120mg with placebo during IUD contraceptives insertion,To compare the efficacy of Etoricoxib 120mg with placebo during IUD contraceptives insertion
Placebo Comparator Drug,No Intervention Drug
Study drug group,Placebo group

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: - Women who desired for IUD insertion - Aged of 18 to 45 years old - BMI between 18.5 – 30.0 kg/m2 - Agree to join the research

Exclusion criteria

Exclusion criteria: Women who contraindicated for IUD used - Could not be ruled out pregnancy - Had some degrees of physiological or anatomical distortion of uterus - Recent pelvic inflammatory disease or prone to be - Had confronted unexplained bleeding from genitalia - Wilson’s disease - Allergy to chemical agents in IUD Contraindicated to etoricoxib used - Allergy to chemical agents in the drug - History of asthma - Allergy to aspirin or others NSAIDs - Heart failure - Poor controlled high blood pressure (>140/90mmHg) - History of ischemic heart, arteriole-venous disease, cerebrovascular disease and who had history of surgery of all above - Used to have any medication which related to liver function

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Etoricoxib 120mg with placebo during IUD contraceptives insertion 1hr before insertion,immediately after insertion, and 15minutes after insertion Visual analog scales,To compare the efficacy of Etoricoxib 120mg with placebo during IUD contraceptives insertion 1hr before insertion,immediately after insertion, and 15minutes after insertion Visual analog scales—

Secondary

MeasureTime frame
Factors related to the pain during insertion, side effects of etoricoxib as study drugs Before and after study drug intake Questionaires—

Countries

Thailand

Contacts

Public ContactSiwaporn Peerananrangsee

Unaffiliated.

regalo2532@hotmail.com66890089106, 6624194636

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026